Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 10 November 2022, Radforsk Investeringstiftelse, a closely associated party of Jónas Einarsson, a primary insider and chair of the board of the Company, has today bought 5,250 shares in the company at an average price of NOK 94.5580 per share. Following this transaction, Radforsk Investeringsstiftelse hold 1,512,163 shares in Ultimovacs ASA.
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Attachment
Upcoming Life Sciences Events
- April 2024
- London: LSX World Congress
- May 2024
- London: London BioTechnology Show 2024
- Seoul: BIO KOREA 2024
Latest company news
There are currently no news available for this portal